Atrás
Rango del Día
$35.44
$36.34
Rango de 52 Semanas
$21.97
$48.25
Volumen
221,362
Promedio 50D / 200D
$39.51
/
$39.76
Cierre Anterior
$35.70
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 177.1 | 0.2 |
| P/B | 3.9 | 3.0 |
| ROE % | 2.7 | 3.6 |
| Net Margin % | 2.2 | 3.8 |
| Rev Growth 5Y % | 10.2 | 9.9 |
| D/E | 0.7 | 0.2 |
Precio Objetivo de Analistas
Hold
$52.00
+44.0%
Low: $50.00
High: $55.00
P/E Futuro
101.15
EPS Futuro
$0.36
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
494.14M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.72
$1.69 – $1.73
|
787.30M | 1 |
| FY2029 |
$1.33
$1.31 – $1.34
|
697.90M | 1 |
| FY2028 |
$0.87
$0.76 – $0.97
|
616.15M | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | $0.06 | $0.17 | +203.6% |
| 2025-11-06 | $0.14 | $0.16 | +14.3% |
| 2025-08-07 | $0.11 | $0.24 | +118.2% |
| 2025-05-05 | $0.12 | $0.06 | -50.0% |
| 2025-02-24 | $0.12 | -$0.39 | -425.0% |
| 2024-11-07 | $0.10 | $0.12 | +20.6% |
| 2024-08-08 | -$0.49 | $0.07 | +114.3% |
| 2024-05-06 | $0.02 | $0.06 | +170.3% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Dec 09, 2015 | Dec 18, 2015 | $0.03 | 1.15% |
| Sep 09, 2015 | Sep 18, 2015 | $0.03 | 1.24% |
| Jun 10, 2015 | Jun 19, 2015 | $0.03 | 1.07% |
| Mar 11, 2015 | Mar 20, 2015 | $0.03 | 1.16% |
| Dec 10, 2014 | Dec 19, 2014 | $0.03 | 1.12% |
| Sep 10, 2014 | Sep 19, 2014 | $0.03 | 1.15% |
| Jun 11, 2014 | Jun 20, 2014 | $0.03 | 1.25% |
| Mar 12, 2014 | Mar 21, 2014 | $0.03 | 1.16% |
| Dec 11, 2013 | Dec 20, 2013 | $0.03 | 1.06% |
| Sep 11, 2013 | Sep 20, 2013 | $0.03 | 1.64% |
| Jun 12, 2013 | Jun 21, 2013 | $0.03 | 1.67% |
| Mar 12, 2013 | Mar 21, 2013 | $0.03 | 1.22% |
| Dec 12, 2012 | Dec 21, 2012 | $0.03 | 0.83% |
| Sep 12, 2012 | Sep 21, 2012 | $0.03 | 0.45% |
Puntos Clave
Revenue grew 10.24% annually over 5 years — strong growth
ROE of 2.70% is below average
Negative free cash flow of -911,000.0
P/E of 177.06 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.35%
Capital efficient — spends only 8.85% of revenue on capex
Crecimiento
Revenue Growth (5Y)
10.24%
Revenue (1Y)13.59%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
2.70%
ROIC2.71%
Net Margin2.21%
Op. Margin6.06%
Seguridad
Debt / Equity
0.65
Current Ratio2.99
Interest Coverage1.01
Valoración
P/E Ratio
177.06
Forward P/E101.15
P/B Ratio3.86
EV/EBITDA73.16
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.59% | Revenue Growth (3Y) | 11.65% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 10.24% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 441.33M | Net Income (TTM) | 9.77M |
| ROE | 2.70% | ROA | 1.10% |
| Gross Margin | 61.28% | Operating Margin | 6.06% |
| Net Margin | 2.21% | Free Cash Flow (TTM) | -911,000.0 |
| ROIC | 2.71% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.65 | Current Ratio | 2.99 |
| Interest Coverage | 1.01 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 177.06 | Forward P/E | 101.15 |
| P/B Ratio | 3.86 | P/S Ratio | 3.92 |
| PEG Ratio | -1.25 | Forward PEG | N/A |
| EV/EBITDA | 73.16 | Fwd EV/EBITDA | 40.63 |
| Forward P/S | 3.50 | Fwd Earnings Yield | 0.99% |
| FCF Yield | -0.05% | ||
| Market Cap | 1.73B | Enterprise Value | 1.96B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 441.33M | 388.54M | 354.00M | 313.79M | 298.84M |
| Net Income | 9.77M | -13.36M | -30.69M | -19.19M | -14.83M |
| EPS (Diluted) | 0.21 | -0.32 | -0.75 | -0.48 | -0.38 |
| Gross Profit | 270.45M | 248.78M | 229.18M | 202.52M | 197.51M |
| Operating Income | 26.75M | 38.87M | 5.74M | 6.20M | 8.12M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 884.80M | 789.10M | 792.40M | 762.80M | 793.05M |
| Total Liabilities | 436.56M | 512.90M | 510.62M | 478.47M | 492.32M |
| Shareholders' Equity | 448.23M | 276.20M | 281.78M | 284.33M | 300.73M |
| Total Debt | 292.04M | 362.26M | 358.34M | 356.83M | 362.04M |
| Cash & Equivalents | 64.91M | 53.46M | 58.94M | 39.35M | 55.01M |
| Current Assets | 303.55M | 290.08M | 280.67M | 247.33M | 247.70M |
| Current Liabilities | 101.56M | 66.82M | 57.86M | 49.68M | 44.95M |